FLESHER GREGORY J. 4
4 · Novus Therapeutics, Inc. · Filed Mar 15, 2018
Insider Transaction Report
Form 4
FLESHER GREGORY J.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2018-03-13+30,700→ 146,556 total - Award
Stock Option (Right to Buy)
2018-03-13+56,500→ 56,500 totalExercise: $4.83Exp: 2028-03-13→ Common Stock (56,500 underlying)
Footnotes (2)
- [F1]This represents restricted stock units representing the right to receive shares of the Issuer's Common Stock, which will vest in full on the later of achievement of a performance-related goal or the first anniversary of the grant date.
- [F2]This option represents a right to purchase a total of 56,500 shares of the Issuer's Common Stock, one quarter of which will become fully vested and exercisable on March 13, 2019, with the remaining 42,375 shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.